Abstract
Aims: In clinical trials, disability progression in multiple sclerosis (MS) is measured by the Kurtzke expanded disability status scale (EDSS), which is not captured in routine clinical care in the U.S. This study developed a claims-based disability score (CDS) based on the EDSS for assigning MS disability level in a U.S. claims database. Methods: This retrospective cohort study of patients with MS in the U.S., utilized adjudicated health plan claims data linked to electronic medical records (EMRs) data. Patients were identified between 1 January 2012 and 31 December 2016 and indexed on the first date of MS diagnosis. The CDS was developed to assign disability level at baseline using claims and ambulatory EMR records observed over the 1-year baseline period. All-cause healthcare costs were assessed by baseline disability level to validate the CDS. Results: In total, 45,687 patients were identified in claims (full sample) and 1,599 linked to EMR (core sample). Over half of patients in both samples were classified with mild disability at baseline. Adjusted healthcare costs in patients with moderate and severe disability were 15% (p
Author supplied keywords
Cite
CITATION STYLE
Berkovich, R., Fox, E., Okai, A., Ding, Y., Gorritz, M., Bartolome, L., … Russo, P. (2021). Identifying disability level in multiple sclerosis patients in a U.S.-based health plan claims database. Journal of Medical Economics, 24(1), 46–53. https://doi.org/10.1080/13696998.2020.1857257
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.